Clinical Trials Logo

First Episode Psychosis clinical trials

View clinical trials related to First Episode Psychosis.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05310838 Recruiting - Clinical trials for First Episode Psychosis

Optimizing Engagement in Services for First-Episode Psychosis

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This study will compare a 12-session behavioral activation (BA) intervention modified for first-episode psychosis (FEP) to usual community mental health care (i.e., treatment-as-usual; TAU) delivered over 6 months with a sample of Latinos with FEP and their families. Comparable family group sessions will also be delivered to participants in both conditions. It is expected that BA participants will show better engagement than TAU participants.

NCT ID: NCT05050201 Recruiting - Insomnia Clinical Trials

Implementation of Digital CBT for Insomnia in First Episode Psychosis

Start date: April 20, 2021
Phase: N/A
Study type: Interventional

This study uses mixed methods to investigate the implementation of digital cognitive behavioural therapy for insomnia (Sleepio) in a first episode of psychosis service (FEP). Interviews will be conducted with keyworker clinicians and service users to consider their expectations for digital sleep intervention. The rates of recruitment into the study, eligibility, completion of baseline measures, completion of the intervention sessions, attrition from the intervention and completion of follow up measures will be recorded. Interviews will be conducted with keyworker clinicians and service users to consider their experiences of digital sleep intervention. The primary outcome will be a logic model describing factors acting upon the implementation of Sleepio in this population. The investigators will provide signal data in relation to changes in insomnia severity, psychosis symptomatology, and general mental health.

NCT ID: NCT04889911 Recruiting - Clinical trials for First Episode Psychosis

Pilot RCT of Self-stigma Treatment for First Episode Psychosis

NECT-YA
Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The overall purpose of the proposed exploratory intervention development application, is to conduct research that will inform the adaptation and preliminary testing of NECT modified for youth (aged 15-24) with first episode psychosis (FEP), targeting self-concept and illness conceptions to increase treatment engagement. The specific aims of the project are to: 1) adapt NECT to be responsive to the needs and preferences of youth with FEP, and 2) Assess the feasibility, acceptability and preliminary effectiveness of the modified intervention (NECT-YA) combined with coordinated specialty care (CSC) services, compared to CSC services alone, in a small (n = 40) RCT.

NCT ID: NCT04853485 Recruiting - Clinical trials for First Episode Psychosis

Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The present study plans to explore different cortical targets of repetitive transcranial magnetic stimulation (rTMS) for populations at the early phase of psychosis, including those at clinical high risk of psychosis and in the first episode of psychosis. The clinical augmentation efficacy will be associated with the brain functional connectivity of these populations.

NCT ID: NCT04368039 Recruiting - Schizophrenia Clinical Trials

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

Start date: December 4, 2019
Phase: N/A
Study type: Interventional

Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.

NCT ID: NCT04298450 Recruiting - Schizophrenia Clinical Trials

ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

Psychosis is a disabling condition that typically has its onset in adolescence and early adulthood. Many young people with psychosis have difficulty navigating services or are reluctant to engage in treatment until their illness becomes an emergency. Consequently, nearly half of all new psychotic disorders are diagnosed in the emergency department (ED). Despite the rationale and evidence for early psychosis intervention (EPI), around half of youth do not access these services. The investigators will use short message service (SMS)/text messaging, a low-cost, low-complexity, youth-friendly approach, to improve transitions in care from the ED and related acute services to EPI services, investigating the intervention's effect on attendance at the first consultation appointment, longer term service engagement, and system-level outcomes. The investigators will also evaluate cost-effectiveness and user perspectives of the intervention.

NCT ID: NCT04046497 Recruiting - Clinical trials for First Episode Psychosis

Artificial Intelligence to Measure Adherence to Oral Medication

Start date: November 20, 2020
Phase: Phase 4
Study type: Interventional

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

NCT ID: NCT04021719 Recruiting - Clinical trials for First Episode Psychosis

OnTrackNY's Learning Healthcare System

Start date: August 15, 2019
Phase:
Study type: Observational

This application proposes OnTrackNY as a regional scientific hub for the Early Psychosis Intervention Network (EPINET) program as part of the National Institute of Mental Health (NIMH)'s creation of a national learning health care system (LHS) for early psychosis care. OnTrackNY has grown into a 22-site network, under the leadership of Lisa Dixon, MD, MPH. Created and supported by the New York State's Office of Mental Health (OMH), OnTrackNY is a nationally recognized model providing coordinated specialty care (CSC) for adolescents and young adults within two years of the onset of non-affective psychosis. OMH regulates and licenses all mental health programs in New York and is a direct-services provider via state-operated programs statewide. This makes OMH an ideal partner for establishing a statewide learning health care system for early psychosis care. Further, OnTrackNY's administration, OnTrackCentral, operates within the OMH-supported Center for Practice Innovations at Columbia Psychiatry. In this model, OnTrackCentral serves as the hub and the 22 OnTrackNY programs serve as the spokes. Since 2014, the still-growing OnTrackNY network has served over 1,600 individuals. From its inception, OnTrackNY has aimed to deliver high-quality, data-driven, accountable and culturally competent care consistent with an LHS. As a condition of funding, all OnTrackNY providers follow established protocols that require submission of patient- and site-level standard measures of early psychosis clinical features, services, and treatment outcomes. The proposed EPINET regional hub, the OnTrackNY LHS, will emphasize and enhance two critical foundational components - Aim 1: proactively engage stakeholders to optimize understanding of key problems and their solutions at every LHS phase; and Aim 2: develop data systems with enhanced standardized data collection, including post-discharge data and linkages to external data systems, and enhancing data analytics that will allow for client-level treatment planning and prospective analytics, delivering real time, dynamic and actionable information to stakeholders. These LHS components do not follow in a stepwise sequence but instead operate in parallel and interact to facilitate and enhance quality improvement processes. This backbone will support the development of practice-based research.

NCT ID: NCT04005378 Recruiting - Clinical trials for First Episode Psychosis

Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

Start date: July 1, 2020
Phase: Phase 4
Study type: Interventional

Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.

NCT ID: NCT04004364 Recruiting - Clinical trials for First Episode Psychosis

Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes

ESPRITO
Start date: April 1, 2020
Phase:
Study type: Observational

The goal if the project is to develop a learning health network devoted to the treatment of first episode psychosis.